IGHE and cystic fibrosis: Our group previously found a correlation between T2 inflammation, based on peripheral eosinophilia and total IgE, frequent exacerbations and lung function decline, based on peripheral eosinophilia and IgE levels and we have reported on the ability of eosinophil-targeting therapeutics to produce beneficial outcomes in CF patients [12, 13].